Astec Lifesciences Ltd.
ShareASTEC Competitor Analysis
| ASTEC | PIIND  | UPL | SUMICHEM | BAYERCROP | |
|---|---|---|---|---|---|
Overview | |||||
| Current price (₹) As on 30 Sept, 2025, 03:45 PM | 804.70 -0.95% | 3,513.50 0.61% | 655.80 0.24% | 533.25 0.35% | 4,810.50 -2.31% |
| Market cap (₹ Cr) | 1,804 | 53,306 | 52,264 | 26,617 | 21,619 |
Report Card | |||||
| Quality | |||||
| Growth | |||||
| Momentum | |||||
| Value | |||||
Past ReturnsAbsolute Returns Shown | |||||
| 1D | -0.82% | 0.13% | 0.96% | -0.76% | -2.48% |
| 1W | -2.11% | -3.68% | -3.4% | -6.31% | -2.92% |
| 1M | -6.91% | -5.48% | -8.6% | -6.14% | -5.88% |
| 3M | -12.14% | -14.92% | -1.07% | 0.34% | -21.77% |
| 6M | 20.31% | 1.87% | 2.82% | -5% | 0.29% |
| 1Y | -31.59% | -24.99% | 6.69% | -4.56% | -23.2% |
| 5Y | -25.1% | 77.14% | 30.09% | 84.51% | -16.42% |
Income StatementAnnual data as on 30 Sept 2025. All values in ₹ Cr. YoY growth displayed | |||||
| Sales | 381.3 -16.78% | 7,978 4.07% | 46,637 8.21% | 3,149 10.72% | 5,473 7.25% |
| OPM (%) | -17.11 -1247.24% | 26.18 2.31% | 16.13 54.8% | 19.34 19.83% | 12.33 -32.99% |
| PBT | -140.99 -128.32% | 2,138 13.48% | 1,301 170.51% | 680.24 35.25% | 707.4 -24.86% |
PAT | -134.71 -187.29% | 1,656 -0.9% | 1,292 178.97% | 506.44 36.97% | 568 -23.3% |
| Net Profit Margin | -35.33 -245.36% | 20.81 -5.15% | 1.76 140.37% | 16.09 23.77% | 10.38 -28.46% |
| EPS | -68.71 -187.13% | 109.43 -1.26% | 10.62 166.42% | 10.13 36.89% | 126.38 -23.3% |
Balance Sheet & Cash FlowAnnual data as on 30 Sept 2025. All values in ₹ Cr. YoY growth displayed | |||||
| Net Worth | 234.75 -36.37% | 10,157 16.33% | 29,213 17.76% | 2,901 18.8% | 2,850 0.04% |
| Total Assets | 881.42 -9.59% | 12,277 14.06% | 88,002 0.52% | 3,964 19.65% | 5,246 14.12% |
| Total Outside Liabilities | 646.68 6.71% | 2,120 4.28% | 58,789 -6.3% | 1,063 21.95% | 2,396 37.07% |
| Cash from Operating Activity | -8.4 -182.19% | 1,413 -30.6% | 10,151 457.14% | 452.73 -40.21% | 262 -72.47% |
| Cash from Investment Activity | -15.23 88.73% | -1,424 20.93% | -1,840 25.75% | -392.06 6.74% | 85.6 21300% |
| Cash from Financing Activity | 23.73 -81.01% | -286.5 -29.29% | -4,793 -3022.56% | -69.08 79.5% | -619.4 5.62% |
| Net Cash Flow | 0.1 -90% | -294.2 -2231.88% | 3,535 14829.17% | -8.4 -3130.77% | -271.8 -191.92% |
RatiosAnnual data as on 30 Sept 2025. | |||||
| PB | 5.64 | 5.12 | 1.73 | 9.61 | 7.76 |
| PE | N.A. | 32.11 | 58.27 | 52.66 | 36.49 |
| ROE (%) | -44.63 | 17.53 | 4.78 | 18.96 | 19.93 |
| Dividend Yield (%) | 0.19 | 0.46 | 0.91 | 0.23 | 2.60 |
| ROCE (%) | -12.63 | 22.70 | 10.05 | 25.68 | 25.42 |
